Animalcare Group Past Earnings Performance
Past criteria checks 2/6
Animalcare Group has been growing earnings at an average annual rate of 65.2%, while the Pharmaceuticals industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 0.3% per year. Animalcare Group's return on equity is 1.5%, and it has net margins of 1.6%.
Key information
65.2%
Earnings growth rate
65.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 14.1% |
| Revenue growth rate | 0.3% |
| Return on equity | 1.5% |
| Net Margin | 1.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Animalcare Group (LON:ANCR) Is Increasing Its Dividend To £0.03
Apr 23
Further Upside For Animalcare Group plc (LON:ANCR) Shares Could Introduce Price Risks After 26% Bounce
Feb 29Even With A 26% Surge, Cautious Investors Are Not Rewarding Animalcare Group plc's (LON:ANCR) Performance Completely
Feb 29Animalcare Group (LON:ANCR) Is Due To Pay A Dividend Of £0.02
Oct 13Estimating The Intrinsic Value Of Animalcare Group plc (LON:ANCR)
Jan 14Animalcare Group (LON:ANCR) Has Announced A Dividend Of £0.02
Oct 18Animalcare Group (LON:ANCR) Has Affirmed Its Dividend Of £0.02
Sep 30Estimating The Intrinsic Value Of Animalcare Group plc (LON:ANCR)
Sep 28Is There An Opportunity With Animalcare Group plc's (LON:ANCR) 20% Undervaluation?
Jun 21Animalcare Group's (LON:ANCR) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Animalcare Group (LON:ANCR) Will Pay A Larger Dividend Than Last Year At UK£0.024
Apr 28Animalcare Group's (LON:ANCR) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 01Animalcare Group (LON:ANCR) Is Due To Pay A Dividend Of UK£0.02
Oct 01Animalcare Group plc (LON:ANCR) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 08We Like These Underlying Return On Capital Trends At Animalcare Group (LON:ANCR)
Jul 10Is Animalcare Group plc (LON:ANCR) A Risky Dividend Stock?
May 10Animalcare Group (LON:ANCR) Has A Pretty Healthy Balance Sheet
Apr 19Animalcare Group (LON:ANCR) Is Reinvesting At Lower Rates Of Return
Mar 29An Intrinsic Calculation For Animalcare Group plc (LON:ANCR) Suggests It's 43% Undervalued
Mar 07If You Had Bought Animalcare Group's (LON:ANCR) Shares Three Years Ago You Would Be Down 27%
Feb 14
Are Poor Financial Prospects Dragging Down Animalcare Group plc (LON:ANCR Stock?
Jan 19Will Animalcare Group (LON:ANCR) Multiply In Value Going Forward?
Dec 23Is Animalcare Group (LON:ANCR) Using Too Much Debt?
Dec 02Revenue & Expenses BreakdownBeta
How Animalcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 74 | 1 | 35 | 3 |
| 30 Sep 23 | 72 | 1 | 34 | 3 |
| 30 Jun 23 | 70 | 1 | 33 | 3 |
| 31 Mar 23 | 71 | 2 | 33 | 3 |
| 31 Dec 22 | 72 | 2 | 32 | 3 |
| 30 Sep 22 | 72 | 2 | 32 | 3 |
| 30 Jun 22 | 73 | 2 | 31 | 3 |
| 31 Mar 22 | 74 | 1 | 31 | 3 |
| 31 Dec 21 | 74 | 0 | 31 | 3 |
| 30 Sep 21 | 75 | 0 | 31 | 3 |
| 30 Jun 21 | 75 | 0 | 32 | 4 |
| 31 Mar 21 | 73 | 0 | 31 | 4 |
| 31 Dec 20 | 70 | 0 | 30 | 3 |
| 30 Sep 20 | 70 | 0 | 30 | 4 |
| 30 Jun 20 | 70 | 1 | 29 | 4 |
| 31 Mar 20 | 70 | 0 | 29 | 4 |
| 31 Dec 19 | 71 | -1 | 29 | 4 |
| 30 Sep 19 | 72 | -2 | 29 | 4 |
| 30 Jun 19 | 73 | -3 | 29 | 5 |
| 31 Mar 19 | 73 | -1 | 29 | 5 |
| 31 Dec 18 | 72 | 0 | 29 | 5 |
| 30 Sep 18 | 72 | 0 | 30 | 4 |
| 30 Jun 18 | 72 | 0 | 30 | 4 |
| 31 Mar 18 | 67 | 0 | 28 | 3 |
| 31 Dec 17 | 62 | 0 | 26 | 3 |
| 31 Dec 16 | 68 | 4 | 22 | 2 |
| 31 Dec 15 | 47 | -1 | 15 | 1 |
| 31 Dec 14 | 34 | 1 | 8 | 0 |
Quality Earnings: ANCR has high quality earnings.
Growing Profit Margin: ANCR's current net profit margins (1.6%) are lower than last year (2.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ANCR has become profitable over the past 5 years, growing earnings by 65.2% per year.
Accelerating Growth: ANCR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ANCR had negative earnings growth (-39%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.6%).
Return on Equity
High ROE: ANCR's Return on Equity (1.5%) is considered low.